Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CD123 CAR-T cell therapy / Chongqing Precision Biotech
NCT04265963: CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia	Recruiting	1/2	45	RoW	CD123 CAR-T cells	Chongqing Precision Biotech Co., Ltd	Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute	12/23	07/24
NCT04272125: Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia	Recruiting	1/2	40	RoW	CD123 CAR-T cells	Chongqing Precision Biotech Co., Ltd	Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute	12/23	07/24